Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Clinton supporters are launching a $35 million digital ad blitz against Trump

Priorities USA Action plans to portray the Republican opponent as unworthy of the presidency.

GOP Republican Candidate Donald Trump Holds Rally In Lynden, Washington
GOP Republican Candidate Donald Trump Holds Rally In Lynden, Washington
Photo by Matt Mills McKnight/Getty Images

The pro-Hillary Clinton super PAC is gearing up a massive digital ad campaign to begin attacking Trump.

Priorities USA Action plans to spend $35 million on digital ads to appear in six battleground states as soon as primary voting ends on June 7. The super PAC will use Facebook, Twitter and other digital platforms to reach women, Latinos, blacks and millennials with ads that cast the presumptive Republican presidential nominee as dangerous and deceptive.

“We’re trying to reach voters where they’re at, and a huge portion of the electorate that we want to target ... get their information more and more online,” said Anne Caprara, executive director of Priorities USA. “So it’s really important that our ad strategy reflects that shift in the way that people consume information and news.”

The super PAC, founded in 2011 by former Obama campaign officials to raise money from wealthy donors in support of the president’s re-election bid, spent about $75 million in that election — mostly on TV ads.

This time around, one-quarter of the $130 million Priorities USA plans to spend buying ads in major markets has been devoted to digital. Those attack ads will likely be in the vein of this one, which began airing Monday night in Ohio, Florida, Nevada and Virginia.

It’s ripped from the headlines — the New York Times’ Sunday story, detailing Trump’s private conduct with women. One of the 50 people interviewed for the article, former girlfriend Rowanne Brewer Lane, subsequently went on Fox News to say her remarks were mischaracterized. By Tuesday morning, an attorney representing Trump demanded a retraction. The Times is standing by its story.

Priorities USA doesn’t get caught up in the details of that dispute. Instead, it uses Trump’s own words to portray him as demeaning to women.

Trump went on social media to criticize the attack ad as misleading.

This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh